HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-Bromoindole → (R)-5-Bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-Bromoindole | HCID 24905 | — |
| Reactant | Eletriptan | HCID 77993 | — |
| Reactant | Phenylmethyl (2R)-2-((5-bromo-1H-indol-3-yl)carbonyl)-1-pyrrolidinecarboxylate | HCID 11224090 | — |
| Reactant | 3-(((2R)-1-Methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethenyl)-1H-indole | HCID 54075398 | — |
| Product | (R)-5-Bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole | HCID 11185464 | — |
Reaction Steps
European Patent No. 0592438 describes the preparation of eletriptan by the catalytic reduction of (R)-5-(2-benzenesulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1 H-indole, which compound is prepared by (i) reacting N-benzyloxycarbonyl-D-proline acid chloride with 5-bromoindole in the presence of a Grignard reagent, (ii) reducing the resulting (R)-3-(N-benzyloxycarbonylpyrrolidin-2-ylcarbonyl)-5-bromo-1H-indole to give (R)-5-bromo-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole and (iii) reacting same with phenyl vinyl sulphone in the presence of a palladium catalyst, a triarylphosphine and a base.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07288662B2 |
| Source dataset | uspto-grants-2007_10 |
| ORD ID | ord-1ae7cdfcbed54c7b9930293e43eaf366 |
| Source note | uspto-grants-2007_10 |